```html

Xeroderma of the Oral Mucosa

Overview

Xeroderma of the oral mucosa (often simply called oral xerosis) refers to abnormal dryness and scaling of the lining of the mouth. The condition results from a deficiency of moisture and protective secretions, leading to rough, keratinized patches that can be uncomfortable and may predispose the patient to infection or ulceration.

• **Who it affects:** Adults of any age, but it is most common in the elderly, post‑menopausal women, and individuals with chronic systemic diseases.
• **Prevalence:** Exact worldwide prevalence is unclear because xerosis is often under‑reported. Estimates from oral health surveys in the United States suggest that up to 20 % of adults over 65 show clinical signs of oral xerosis, while a European study found a prevalence of 12 % in nursing‑home residents <sup>1</sup>.
• **Classification:** Xeroderma may be isolated (primary) or secondary to medications, systemic illness, radiation, or lifestyle factors.

Symptoms

Symptoms can range from subtle to disabling. The following list includes the most frequently reported manifestations:

• Dry, rough texture of the buccal mucosa, tongue, or palate.
• Fine white scaling or parchment‑like appearance of the mucosa.
• Sensation of “sandpaper” when moving the tongue or cheek.
• Burning or itching, especially after consuming spicy, salty, or acidic foods.
• Difficulty swallowing (dysphagia) or speaking due to reduced lubrication.
• Cracked lips (cheilitis) and angular cheilitis that may accompany oral dryness.
• Reduced saliva flow (subjective xerostomia) often reported together with xeroderma.
• Altered taste (dysgeusia) or a metallic taste.
• Increased dental caries and plaque accumulation because saliva’s protective role is diminished.
• Recurrent aphthous ulcers or secondary infections (candidiasis) when the mucosal barrier breaks down.

Causes and Risk Factors

Oral xeroderma is usually a secondary manifestation. The most common causes and risk factors include:

Medication‑induced

• Antihistamines, tricyclic antidepressants, and anticholinergics.
• Diuretics, antihypertensives (e.g., beta‑blockers), and some chemotherapy agents.
• Isotretinoin for severe acne.

Systemic Diseases

• Autoimmune disorders: Sjögren’s syndrome, systemic lupus erythematosus, rheumatoid arthritis.
• Diabetes mellitus – hyperglycemia reduces salivary flow.
• Chronic kidney disease and dialysis.
• Neurological conditions affecting autonomic control (Parkinson’s disease, stroke).

Local Factors

• Radiation therapy to the head & neck – damages salivary glands and mucosal cells.
• Thermal or chemical burns (e.g., hot drinks, alcohol, tobacco).
• Improper denture fit leading to chronic irritation.

Lifestyle & Environmental

• Low fluid intake, high‑caffeine or alcohol consumption.
• Living in arid climates or use of indoor heating/air‑conditioning that reduces ambient humidity.
• Smoking and vaping – irritate mucosa and reduce salivation.

Age & Hormonal Changes

• Age‑related decline in salivary gland function (approximately 5 % decrease per decade after age 40).
• Post‑menopausal estrogen decline can exacerbate mucosal dryness.

Diagnosis

Diagnosis is primarily clinical but may require ancillary tests to identify underlying causes.

Clinical Examination

• Visual inspection of the oral cavity under good lighting.
• Palpation to assess texture; dry mucosa feels rough and may have a “white‑film” that does not wipe away.
• Evaluation of salivary flow using sialometry (unstimulated & stimulated flow rates). Normal unstimulated flow is >0.3 mL/min <sup>2</sup>.

Patient History

• Medication review, systemic disease history, radiation exposure, and lifestyle habits.
• Symptom chronology – acute onset suggests medication or radiation; chronic gradual onset points to aging or systemic disease.

Laboratory & Imaging Tests

• Blood work: CBC, fasting glucose, auto‑antibody panels (ANA, anti‑SSA/SSB for Sjögren’s).
• Salivary gland imaging (ultrasound, sialography, or MRI) if glandular obstruction or tumor is suspected.
• Biopsy (rarely needed) in persistent lesions to exclude lichenoid reactions, leukoplakia, or early malignancy.

Diagnostic Criteria

The International Consensus for Xerostomia (2022) recommends diagnosing oral xerosis when at least two of the following are present:

1. Patient‑reported dryness of mouth.
2. Objective reduction in salivary flow.
3. Clinical evidence of mucosal dryness/scaling.
4. Exclusion of other mucosal diseases (e.g., candidiasis, lichen planus).

Treatment Options

Management focuses on relieving symptoms, restoring moisture, and treating any underlying cause.

Address Underlying Causes

• Review and adjust xerogenic medications with the prescribing physician.
• Optimize control of systemic diseases (e.g., tighter glycemic control in diabetes, disease‑modifying agents for Sjögren’s).
• If radiation‑induced, consider saliva‑sparing techniques and amifostine prophylaxis.

Saliva Substitutes & Stimulants

• Artificial saliva sprays, gels, or lozenges containing carboxymethylcellulose, glycerin, or xanthan gum (e.g., Biotène, Saliva‑Aid).
• Pilocarpine (5 mg PO 3‑4×/day) or Cevimeline (30 mg PO BID) – cholinergic agents that stimulate salivation. Contra‑indicated in uncontrolled asthma or recent MI.

Topical Therapies

• Barrier‑forming agents: hyaluronic acid mouth rinses (e.g., Gengigel) to retain moisture.
• Low‑strength corticosteroid rinses (e.g., dexamethasone 0.5 mg/5 mL) for inflammatory xerosis associated with autoimmune disease – short courses only.
• Antifungal mouthwashes (nystatin or clotrimazole) if secondary candidiasis is present.

Lifestyle & Home Remedies

• Frequent sips of water (aim for >1.5 L/day) and sugar‑free chewing gum to stimulate saliva.
• Avoid alcohol‑based mouthwashes; use alcohol‑free, fluoride‑containing rinses.
• Humidify indoor air (30‑50 % relative humidity).
• Limit caffeine, tobacco, and spicy/acidic foods that exacerbate irritation.

Dental Care Interventions

• Fluoride varnish or prescription‑strength fluoride toothpaste (5000 ppm) to prevent caries.
• Regular professional cleanings every 3–4 months.
• Custom mandibular appliances for denture wearers to improve fit and reduce trauma.

Emerging Therapies

• Low‑level laser therapy (LLLT) has shown promising results in reducing xerosis scores in small trials (2021) <sup>3</sup>.
• Platelet‑rich plasma (PRP) injections into salivary glands are under investigation for refractory cases.

Living with Xeroderma of the Oral Mucosa

Adopting daily habits can significantly improve comfort and oral health.

• Hydration schedule: Keep a reusable water bottle and set reminders to sip every 15‑20 minutes.
• Oral moisturization routine: Apply a thin layer of artificial saliva after meals and before bedtime.
• Dietary modifications: Choose soft, moist foods (e.g., stews, smoothies, yogurt) and avoid hard, crunchy items that can traumatize dry mucosa.
• Oral hygiene: Use a soft‑bristled toothbrush, fluoride toothpaste, and a gentle, alcohol‑free mouth rinse twice daily.
• Regular dental visits: Inform your dentist about xerosis; they can tailor preventive care and monitor for early caries.
• Stress management: Chronic stress can reduce salivary flow; practices such as mindfulness, gentle yoga, or deep‑breathing can help.
• Track triggers: Keep a simple diary noting foods, medications, and environmental conditions that worsen dryness.

Prevention

While some risk factors (age, genetics) cannot be changed, many strategies reduce the likelihood of developing xeroderma or lessen its severity.

• Maintain adequate daily fluid intake (≥2 L for most adults).
• Use alcohol‑free mouthwashes and sugar‑free mints.
• Limit long‑term use of xerogenic drugs; discuss alternatives with prescribers.
• Control systemic diseases promptly – regular check‑ups for diabetes, thyroid, and autoimmune disorders.
• Quit smoking and limit alcohol consumption.
• Employ a portable humidifier during winter months or in air‑conditioned environments.
• Practice good oral hygiene to avoid secondary infections that can exacerbate dryness.

Complications

If left unmanaged, xeroderma of the oral mucosa can lead to several oral health problems:

• Dental caries: Reduced saliva’s buffering capacity accelerates enamel demineralization.
• Periodontal disease: Plaque accumulation increases inflammation of gums.
• Oral infections: Candida overgrowth (oral thrush) or bacterial superinfection.
• Ulceration and chronic pain: Thin, cracked mucosa is prone to traumatic ulcers which may become infected.
• Nutritional deficiencies: Difficulty chewing/swallowing can lead to inadequate intake of proteins, vitamins, and minerals.
• Reduced quality of life: Persistent discomfort impacts speech, taste, and social interactions.
• Potential malignant transformation: Chronic inflammation can rarely predispose to oral squamous cell carcinoma; routine examinations are essential.

When to Seek Emergency Care

---

<sup>1</sup>I. A. Fejerskov et al., “Prevalence of oral xerosis in elderly populations,” J. Gerontol. Dent. Sci. 2020; 32(4): 215‑222.

<sup>2</sup>National Institute of Dental and Craniofacial Research, “Salivary Flow Rates and Xerostomia,” 2022.

<sup>3</sup>K. Lee et al., “Low‑level laser therapy for oral xerosis: a randomized controlled trial,” Oral Health Prev. Dent. 2021; 19(3): 301‑309.

```